For Doctors

There is a body of evidence supporting the role of SXRT in the management of non-melanoma skin cancer. The first publication in treating skin cancer with SXRT was published in 1902, proving the effective eradication of a ‘rodent ulcer’ in the facial skin of a patient.

With the development of megavoltage therapy and linear accelerators and with surgery becoming the standard of care in managing non-melanoma skin cancers, the use of SXRT has diminished over time.

Over the past decade, SXRT has undergone a renaissance in the management of inoperable skin cancer. Technically all skin cancers are operable, but surgery is not always the best treatment option.

With SXRT offering comparative results to surgery, SXRT should be part of the informed consent discussion for every non-melanoma skin cancer.

Our results attest to the efficacy of SXRT in the management of non-melanoma skin cancer. We offer selected in-house resources and references on the benefits of SXRT in the management of non-melanoma skin cancer.

For more information, please get in touch.

Recommended Reading

Group of doctors on conference, medical team sitting and listening
doctor and patient

For Patients

In case you missed out, here are the important documents and fine print:

Articles & Videos

Resources 1

How does a Superficial X-ray Therapy Machine work?

There are many types of radiation therapy machines, each suited to a different purpose. Some create radiation strong enough to go through an entire body, some barely penetrate deeper than the first few millimeters of skin. The machines at Just Skin fall into the later category which can dramatically reduce side effects by minimizing irradiation to healthy tissues.

Producing this radiation safely and consistently requires many finely engineered parts working together.

At Just Skin we use an Xstrahl 100 machine. In this post, Kurt Byrnes our Medical Physicist explains how these machines work.

Young woman seeing doctor for dermatological examining